BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaufman NEM, Dhingra S, Jois SD, Vicente MDGH. Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). Molecules 2021;26:1076. [PMID: 33670650 DOI: 10.3390/molecules26041076] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
Number Citing Articles
1 Judmann B, Braun D, Schirrmacher R, Wängler B, Fricker G, Wängler C. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors. ACS Omega. [DOI: 10.1021/acsomega.2c03407] [Reference Citation Analysis]
2 Jin C, Luo X, Li X, Zhou R, Zhong Y, Xu Z, Cui C, Xing X, Zhang H, Tian M. Positron emission tomography molecular imaging-based cancer phenotyping. Cancer 2022. [PMID: 35417604 DOI: 10.1002/cncr.34228] [Reference Citation Analysis]
3 Haider K, Das S, Joseph A, Yar MS. An appraisal of anticancer activity with structure-activity relationship of quinazoline and quinazolinone analogues through EGFR and VEGFR inhibition: A review. Drug Dev Res 2022. [PMID: 35297084 DOI: 10.1002/ddr.21925] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yin L, Zhan J, Liao H, Qiu W, Hou W, Li S, Zhang J. Novel vandetanib derivative inhibited proliferation and promoted apoptosis of cancer cells under normoxia and hypoxia. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174907] [Reference Citation Analysis]
5 Bolcaen J, Nair S, Driver CHS, Boshomane TMG, Ebenhan T, Vandevoorde C. Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma. Pharmaceuticals (Basel) 2021;14:626. [PMID: 34209513 DOI: 10.3390/ph14070626] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Zhou H, He Y, Zhu J, Lin X, Chen J, Shao C, Wan H, Yang J. Guhong Injection Protects Against Apoptosis in Cerebral Ischemia by Maintaining Cerebral Microvasculature and Mitochondrial Integrity Through the PI3K/AKT Pathway. Front Pharmacol 2021;12:650983. [PMID: 34054531 DOI: 10.3389/fphar.2021.650983] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]